Roper Martin 4
4 · Vita Coco Company, Inc. · Filed Apr 28, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) CEO Martin Roper Exercises Options, Sells Shares
What Happened
- Martin Roper, CEO of Vita Coco Company, exercised a total of 50,000 stock options (25,000 on 2026-04-24 and 25,000 on 2026-04-27) at a strike price of $10.18, paying $508,900 in exercise costs. He sold the 50,000 resulting shares in two open-market transactions (25,000 shares each day) at $50.00 per share, generating $2,500,000 in gross proceeds. The Form 4 also reports the related derivative conversions at $0.00, reflecting the option-to-share conversion.
Key Details
- Transaction dates and prices:
- 2026-04-24: exercised 25,000 options @ $10.18 (cost $254,450); sold 25,000 shares @ $50.00 (proceeds $1,250,000).
- 2026-04-27: exercised 25,000 options @ $10.18 (cost $254,450); sold 25,000 shares @ $50.00 (proceeds $1,250,000).
- Net proceeds (approx.): $2,500,000 gross sales − $508,900 exercise cost = ~$1,991,100 before taxes/fees.
- Sales were effected pursuant to a Rule 10b5‑1 trading plan (footnote F1).
- The filing was submitted 2026-04-28 for transactions on 2026-04-24 and 2026-04-27 — within the SEC’s two-business-day Form 4 reporting window.
- Shares owned after the transactions are not specified in the information provided in this Form 4.
Context
- This was essentially a same-day exercise-and-sell (cashless-style) sequence: options were exercised and the resulting shares were sold shortly thereafter. Such transactions are often executed under pre-established 10b5‑1 plans and can be routine liquidity events rather than a clear signal about the CEO’s view of the company. The Form’s derivative entries at $0.00 reflect conversion/cancellation of the exercised options.
Insider Transaction Report
Form 4
Roper Martin
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2026-04-24$10.18/sh+25,000$254,450→ 323,484 total - Sale
Common Stock
[F1]2026-04-24$50.00/sh−25,000$1,250,000→ 298,484 total - Exercise/Conversion
Common Stock
2026-04-27$10.18/sh+25,000$254,450→ 323,484 total - Sale
Common Stock
[F1]2026-04-27$50.00/sh−25,000$1,250,000→ 298,484 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F5]2026-04-24−25,000→ 400,214 totalExercise: $10.18Exp: 2029-09-19→ Common Stock (25,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F5]2026-04-27−25,000→ 375,214 totalExercise: $10.18Exp: 2029-09-19→ Common Stock (25,000 underlying)
Holdings
- 215,631(indirect: by Chris Roper FT)
Common Stock
[F2] - 216,131(indirect: by Peter Roper FT)
Common Stock
[F3] - 216,131(indirect: by Thomas Roper FT)
Common Stock
[F4] - 41,200(indirect: By Spouse)
Common Stock
- 40,950
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $10.18Exp: 2031-01-11→ Common Stock (40,950 underlying) - 298,507
Non-Qualified Stock Option (Right to Buy)
[F6]Exercise: $15.00Exp: 2031-10-21→ Common Stock (298,507 underlying) - 46,875
Non-Qualified Stock Option (Right to Buy)
[F7]Exercise: $16.91Exp: 2033-03-10→ Common Stock (46,875 underlying) - 185,133
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $16.91Exp: 2033-03-10→ Common Stock (185,133 underlying) - 62,743
Non-Qualified Stock Option (Right to Buy)
[F8]Exercise: $26.18Exp: 2034-03-04→ Common Stock (62,743 underlying) - 70,715
Non-Qualified Stock Option (Right to Buy)
[F9]Exercise: $32.78Exp: 2035-03-03→ Common Stock (70,715 underlying)
Footnotes (9)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]These shares are held by the Christopher G. Roper Exempt Family Trust.
- [F3]These shares are held by the Peter S. Roper Exempt Family Trust.
- [F4]These shares are held by the Thomas L. Roper Exempt Family Trust.
- [F5]The stock option is fully vested and currently exercisable.
- [F6]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F7]The stock option vests in four equal annual installments beginning on March 10, 2024.
- [F8]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F9]The stock option vests in four equal annual installments beginning on March 3, 2026.
Signature
/s/ Alison Klein, attorney-in-fact for Martin Roper|2026-04-28